NATIONAL EXPERIENCE WITH WEARABLE CARDIOVERTER-DEFIBRILLATOR USE IN TAKOTSUBO CARDIOMYOPATHY

被引：5
|
作者：
Deeprasertkul, Peerawut
Opreanu, Madalina
Bianco, Nicole
Thakur, Ranjan
机构：
[1] Thorac & Cardiovasc Inst, Lansing, MI USA
[2] Michigan State Univ Sparrow, Lansing, MI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(13)60361-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E361 / E361
页数：1
相关论文
共 50 条
  • [21] Implantable Cardioverter-Defibrillator Use in Nonischemic Cardiomyopathy - A Bayesian Analysis
    Kim, Joonseok
    Parcha, Vibhu
    Li, Peng
    Brar, Vijawant
    Han, Jingnan
    Arora, Garima
    Arora, Pankaj
    CIRCULATION, 2021, 144
  • [22] Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
    Klein, Helmut U.
    Goldenberg, Ilan
    Moss, Arthur J.
    EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2230 - 2242
  • [23] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Anil-Martin Sinha
    Jens Bense
    Wolfgang Hohenforst-Schmidt
    Journal of Interventional Cardiac Electrophysiology, 2021, 62 : 401 - 407
  • [24] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Sinha, Anil-Martin
    Bense, Jens
    Hohenforst-Schmidt, Wolfgang
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 62 (02) : 401 - 407
  • [25] The Implantable cardioverter-defibrillator and hypertrophic cardiomyopathy.: Experience at three centers
    Marin, Francisco
    Gimeno, Juan R.
    Paya, Eduardo
    Garcia-Alberola, Arcadio
    Perez-Alvarez, Luisa
    Fernandez, Xusto
    de la Morena, Gonzalo
    Sogorb, Francisco
    Castro-Beiras, Alfonso
    Valdes, Mariano
    Martinez, Juan G.
    Monserrat, Lorenzo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (06): : 537 - 544
  • [26] WEARABLE CARDIOVERTER-DEFIBRILLATOR - WHERE ARE THE CLINICAL GUIDELINES?
    Agarwal, M.
    Botta, V.
    Gardner, J.
    Khouzam, R.
    CARDIOLOGY, 2016, 134 : 277 - 277
  • [27] Conversion of Recurrent Arrhythmia by the Wearable Cardioverter-defibrillator
    Ringquist, Steven
    Bianco, Nicole R.
    Szymkiewicz, Steven J.
    CIRCULATION, 2015, 132
  • [28] Usage of the wearable cardioverter-defibrillator during pregnancy
    Olic, J-Jacqueline
    Stoellberger, Claudia
    Schukro, Christoph
    Odening, Katja E.
    Reuschel, Edith
    Fischer, Marcus
    Veltmann, Christian
    Duncker, David
    Baessler, Andrea
    IJC HEART & VASCULATURE, 2022, 41
  • [29] Wearable Cardioverter-Defibrillator after Myocardial Infarction
    Fauchier, Laurent
    Clementy, Nicolas
    Bisson, Arnaud
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 599 - 600
  • [30] The Wearable Cardioverter-Defibrillator Is It Now the Standard of Care?
    Lee, Byron K.
    Olgin, Jeffrey E.
    CIRCULATION, 2016, 134 (09) : 644 - 646
12345